Form 4 for INSM INSMED Inc
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-28 · accession 0001628280-24-025890 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-30 | 2024-05-28+ | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale+OE | $50.53 | -125.0K | 106.1K | -54% | -$6.32M |
| DM | 2024-05-30 | 2024-05-28+ | INSM | Flammer Martina M.D. | Chief Medical Off | M - OptEx | $23.68 | +125.0K | 209.9K | +147% | +$2.96M |
| DM | 2024-05-30 | 2024-05-28+ | INSM | Flammer Martina M.D. | Chief Medical Off | M - OptEx | $0.00 | -125.0K | 18.9K | -87% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-30 | S | D | 21,195 | $55.00 | 106,134 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-30 | M | A | 21,195 | $23.75 | 127,329 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-28 | M | A | 103,806 | $23.66 | 209,940 | D | — | — | |
| 4 | Common | Common Stock | 2024-05-28 | S | D | 103,806 | $49.62 | 106,134 | D | — | — | (F2) This is the weighted average sales price representing 103,806 shares sold at prices ranging from $49.53 to $50.00 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 5 | Derivative | Stock Option (right to buy) | 2024-05-30 | M | D | 21,195 | $0.00 | 35,325 | D | $23.75 · — to 2030-01-03 | 21,195 Common Stock | (F3) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 6 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 103,806 | $0.00 | 18,874 | D | $23.66 · — to 2030-01-02 | 103,806 Common Stock | (F3) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |